Andreic Sposito News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A pilot study investigated the dialyzability and pharmacokinetics of dapagliflozin, an SGLT2 inhibitor, in patients on dialysis for kidney failure.

New yorkUnited statesAndreic spositoCidade universitCalvin meaneySciences in buffaloUniversity at buffalo school of pharmacyUniversity of minnesotaClinical journalAmerican societyWendy st peterBuffalo schoolPharmaceutical sciences